Brain Stimulation for Working Memory
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how brain stimulation can improve working memory using a technique called tACS (Transcranial Alternating Current Stimulation). This method applies gentle electrical currents to the scalp to influence brain activity. Participants will receive either active tACS during certain memory tasks or a placebo. The trial is suitable for English speakers without neurological or psychiatric disorders who are not on specific medications. As an unphased trial, it offers participants the chance to contribute to groundbreaking research on brain stimulation and memory enhancement.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications, especially those that affect brain stimulation, like psychotropic drugs and others that alter brain chemicals. It's best to discuss your specific medications with the trial team.
What prior data suggests that transcranial alternating current stimulation (tACS) is safe for modulating brain oscillations?
Research has shown that transcranial alternating current stimulation (tACS) is generally safe. Studies have used both theta-nested gamma tACS and gamma tACS without causing serious side effects.
Theta-nested gamma tACS has improved working memory in young and older adults. This treatment applies weak electric currents to the brain, and most people tolerate it well. No major negative effects were reported in these studies.
Gamma tACS has been tested on healthy individuals and those with mild memory issues. Research suggests it can improve memory and thinking skills when combined with brain exercises. Again, no significant safety concerns were found.
Overall, current research considers both types of tACS used in this trial safe. They are non-invasive, meaning they don't require surgery or internal procedures, which generally lowers the risk.12345Why are researchers excited about this trial?
Researchers are excited about these brain stimulation treatments for improving working memory because they offer a novel approach compared to traditional cognitive therapies or medications. Unlike standard treatments, these techniques use transcranial alternating current stimulation (tACS), which involves applying gentle electrical currents to the brain to potentially enhance memory performance. The treatments are unique in targeting specific brain rhythms, like theta and gamma, during different phases of memory tasks. This targeted stimulation could lead to more precise and effective improvements in working memory, providing new hope for individuals looking for alternatives to current therapies.
What evidence suggests that this trial's treatments could be effective for working memory?
This trial will compare different brain stimulation techniques for working memory. Research has shown that theta-nested gamma tACS, a treatment participants in this trial may receive, can improve working memory. Studies have found it more effective in memory tasks than placebo treatments, with a noticeable impact. This method uses specific electrical patterns to influence brain activity related to memory.
Another treatment option in this trial is gamma tACS, which has shown mixed results. Some studies suggest it can enhance thinking skills, especially in people with mild memory problems. However, its effect on working memory is less reliable compared to theta-nested gamma tACS. Overall, both treatments have potential, but theta-nested gamma tACS is more closely linked to improvements in working memory.678910Who Is on the Research Team?
Hamdi Eryilmaz, Ph.D.
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for individuals who can give informed consent and are fluent in English. It's designed to explore how working memory functions by using a noninvasive brain stimulation technique.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo four tACS sessions with EEG recording before and after each session
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active tACS
- Placebo tACS
Active tACS is already approved in United States, European Union for the following indications:
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor